FDA Recall Terminated

Spectra Optia Apheresis System, REF: 61000, Caridian BCT, Lakewood, CO 80215. A blood component separator used for therapeutic plasma exchanges.

Recall: Z-0191-2012 · Initiated September 21, 2011

Recall

Recall Number
Z-0191-2012
Event Number
60174
Firm
Caridian BCT, Incorporated
FEI Number
1000117351
Product Code
LKN
Status
Terminated
Root Cause
Software design
Initiated
September 21, 2011
Posted
November 16, 2011
Terminated
February 1, 2013
Address
10811 W Collins Ave, Lakewood, CO, 80215-4440

Description

Spectra Optia Apheresis System, REF: 61000, Caridian BCT, Lakewood, CO 80215. A blood component separator used for therapeutic plasma exchanges.

Reason

Possible higher than expected platelet loss following therapeutic plasma exchange or plasmapheresis.

Action

CaridianBCT sent a "Safety Alert" letter dated September 2011, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. The firm will be sending a recall letter to consignees in November 2011, stating they are voluntarily recalling the software and will provide an upgrade once the software has been approved. If you have any further questions please contact your CaridianBCT Representative, the CaridianBCT Support Center at 1-877-3-FYU-BCT ( US Toll free 1-877-299-4228 ) or (303) 231-HELP ) ( 1 (303) 231-4357, or your local CaridianBCT Customer Service office.

Distribution

Worldwide Distribution -- USA ( nationwide ) and the countries of Australia, Belgium, Canada, Chile, China, Colombia, Hong Kong, India, Japan, Malaysia, Mexico, Pakistan, Republic of Korea, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand and Vietnam.

Quantity

852 units (US: 333; Foreign: 519)